MedTrace Logo

Ellipse Intramedullary Nail High Tibial Osteotomy Study

NCT02412163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2017-09-01

No results posted yet for this study

Summary

This study further evaluates the safety profile and efficacy of the Ellipse IM HTO Nail system in subjects with osteoarthritis and varus malalignment of the knee. All subjects will receive treatment with the Ellipse IM HTO Nail System and followed for six months.

Conditions

Interventions

DEVICE

Ellipse IM HTO Nail

Sponsors & Collaborators

  • Ellipse Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Mark T Dahl, MD · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-07-31
Completion
2016-12-31
FDA Device
Yes

Countries

  • Germany
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02412163 on ClinicalTrials.gov